Literature DB >> 3675694

Influence of ambroxol on lung tissue penetration of amoxicillin.

J Spátola1, J J Poderoso, J C Wiemeyer, M Fernández, R B Guerreiro, C Corazza.   

Abstract

Lung amoxicillin levels were assessed in tissue obtained from 16 patients who underwent lung resection due to different pulmonary diseases. In this double-blind placebo controlled study patients were allocated to two groups in randomized order; one group received amoxicillin 1000 mg t.i.d. (n = 8) and the other amoxicillin 1000 mg + ambroxol 60 mg t.i.d. (n = 8). A trend towards higher antibiotic lung tissue levels was observed in patients who received the antibiotic together with the mucolytic agent. The ratio pulmonary tissue/serum amoxicillin levels reached a significant difference being higher in the amoxicillin plus ambroxol group than in the other one (0.411 +/- 0.04 vs 0.672 +/- 0.07; p less than 0.01), even if the amoxicillin plasma levels were lower. A possible effect of ambroxol on lung tissue penetration of amoxicillin is suggested and discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3675694

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  High-dose ambroxol reduces pulmonary complications in patients with acute cervical spinal cord injury after surgery.

Authors:  Qiang Li; Gaiqi Yao; Xi Zhu
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

Review 2.  Enhancement of lung levels of antibiotics by ambroxol and bromhexine.

Authors:  Vojo Deretic; Graham S Timmins
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-02-07       Impact factor: 4.481

3.  Effect of ambroxol on the concentration of cefotaxime in the bronchoalveolar lavage fluid of rats with pulmonary fibrosis.

Authors:  Feng Chen; Yuan-Xia Zhang; Cai-Qing Zhang
Journal:  Exp Ther Med       Date:  2014-12-08       Impact factor: 2.447

Review 4.  Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive?

Authors:  Francesco Scaglione; Orlando Petrini
Journal:  Clin Med Insights Ear Nose Throat       Date:  2019-01-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.